Till startsida
To content Read more about how we use cookies on gu.se

The Intergene- and Adonix-studies

INTERGENE is a study of the interaction between genetic susceptibility, metabolic conditions, lifestyle, environmental factors, psychosocial factors and the risk of cardiovascular disease in western Sweden. Examination of body composition, heart and blood pressure, and blood samples are included. ADONIX is an acronym for Adult-onset asthma and nitric oxide and is the generic name for a study of risk factors for lung diseases, particularly asthma. Measurements of nitric oxide in exhaled air (NO measurement) and spirometry (lung function test) are done. In both studies, the participants answer questionnaires with series of various questions.

Between 2001 and 2008 a total of approximately 7600 people participated in the Intergene- and Adonix studies. The surveys were conducted at Östra Hospital in Gothenburg, and also in a bus in which participants from other parts of Västra Götaland was investigated. From February 2014 to March 2016, about 1300 of the participants came for another examination. The follow-up study is called Intergene Adonix 2 (Ad-In2).

The researchers behind the two studies have been cooperating since 2001. The Intergene study was initiated by Professor Dag Thelle in collaboration with Professor Annika Rosengren and Professor Lauren Lissner. The Adonix study was started by Professor Kjell Torén and Professor Anna-Carin Olin. The latter four are also responsible for the ongoing study.


Elisabeth Strandhagen, 46 31-786 6494

Page Manager: Katarina Englund|Last update: 12/8/2016

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?